- Home
- PYPD vs KULR Comparison
PYPD vs KULR Comparison
Compare PYPD & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PYPD | KULR |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.0M | 116.6M |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PYPD | KULR |
|---|---|---|
| Price | $5.22 | $2.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $12.25 | N/A |
| AVG Volume (30 Days) | 91.4K | ★ 603.2K |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,274,028.00 |
| Revenue This Year | N/A | $123.93 |
| Revenue Next Year | N/A | $63.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.06 | $1.94 |
| 52 Week High | $5.73 | $6.00 |
Technical Indicators
Market Signals| Indicator | PYPD | KULR |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 47.55 |
| Support Level | $4.18 | $2.30 |
| Resistance Level | $5.64 | $3.15 |
| Average True Range (ATR) | 0.25 | 0.10 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 46.02 | 69.12 |
Price Performance
Historical ComparisonAbout PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices. The Company operated two segments -EMP and Mining of Digital Assets.